CAS: 1628256-23-4
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Lerociclib (G1T38) REF: 3D-DQC25623CAS: 1628256-23-4 | Min. 95% | To inquire | Thu 23 Jan 25 |
 | Lerociclib REF: TM-T11345CAS: 1628256-23-4 | 98% | 68.00 €~764.00 € | Thu 13 Feb 25 |
Lerociclib (G1T38)
CAS:1628256-23-4
Lerociclib (G1T38) is a potent inhibitor of breast cancer cells with structural similarity to palbociclib. …
Formula:
C26H34N8O
Purity:
Min. 95%
Molecular weight:
474.61 g/mol
Ref: 3D-DQC25623
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 23 Jan 2025
Lerociclib
CAS:1628256-23-4
Lerociclib (G1T38) is a CDK4/6 inhibitor with anticancer and antitumor activities, inhibiting CDK4/CyclinD1 and CDK6/CyclinD3.
Formula:
C26H34N8O
Purity:
98%
Color and Shape:
Solid
Molecular weight:
474.6
Ref: TM-T11345
| 1mg | 68.00 € | ||
| 5mg | 153.00 € | ||
| 10mg | 217.00 € | ||
| 25mg | 362.00 € | ||
| 50mg | 535.00 € | ||
| 100mg | 764.00 € |
Estimated delivery in United States, on Thursday 13 Feb 2025
